A diabetic foot ulcer is one of diabetes mellitus type 2 complications indicated by open sores. Because it contains bacteria, it is treated with antibiotics. Improper use of antibiotics could harm patients due to the length of wound healing. This study aims to determine the appropriate of antibiotics in patients with a diabetic foot ulcers. This is a non-experimental research with descriptive analysis approach. The medical records of diabetic foot ulcer patients undergoing inpatient and antibiotic prescribing are observed. The data obtained were analyzed by comparing the use of antibiotics based on the National Health Service guidelines, the Indonesian National Drug Information, and the Drug Information Handbook. The results of this study showed antibiotics used are metronidazole (4.8%), vancomycin (4.8%) and antibiotics combination are ceftriaxone-metronidazole (47.6%), ceftriaxone-metronidazole-clindamycin (4,8%), levofloxacin-azithromycin-ceftriaxone (4.8%), cotrimoxazole-ciprofloxacin (4.8%), metronidazole-meropenem (4.8%), ceftriaxone-metronidazole-gentamicin (4.8%), metronidazole-clindamycin-ciprofloxacin (4.8%), ceftriaxone-levofloxacin (4.8%), and ceftriaxone-metronidazole-ciprofloxacin (9.5%). The evaluation results according to criteria appropriate usage of antibiotics that is 100% appropriate indication, 100% for appropriate of patients, 42.3% for appropriate drug, and 61.9% for the appropriate dose.

These articles have been peer reviewed by the members of the Scientific Committee and approved by the Editor-in-Chief, who affirms that this document is a truthful description of the conference's review process. Review ProcedureThe reviews were open. Each submission was examined by 2 reviewers independently.The conference submission management system was REMIT on https://icb-pharma. ums.ac.id/2021/ The submissions were first screened for generic quality and suitableness. Authors choose directly the track that suitable with their articles. The track director then did the initial screening, and sent the article for peer review by matching each article's topic with the reviewers' expertise, taking into account any competing interests. An article could only be considered for acceptance if it had received favourable recommendations from the two reviewers.Authors of a rejected submission were given the opportunity to revise and resubmit after addressing the reviewers' comments. The acceptance or rejection of a revised manuscript was final. Quality CriteriaReviewers were instructed to assess the quality of submissions solely based on the academic merit of their content along the following dimensions:1. Originality and level of innovativeness; 2. Thematic relevance for the call for papers; 3. Significance for theory or practice; 4. Methodology well discussed (Experimental planning and preparation); 5. Quality of Presentation of tables and figures. 6. Conclusion supported by results of work and future work.In addition, all of the articles have been checked for textual overlap in an effort to detect possible signs of plagiarism by the publisher. Turnitin was used to detect the plagiarism.

Indonesian Ministry of Health shows an increase in patients with impaired kidney and liver function by 10-50% since 2007. The increase is a challenge for pharmacists in conducting pharmaceutical care, which is that dose adjustment for these patients takes a long time. Dosing GAMA, an application that has been developed in 2018, is expected to overcome these obstacles. This study aims to identify the use of the Dosing GAMA application to assist pharmacists in making dose adjustments evaluation more efficient and to assess pharmacist's acceptance of the application. This study was a quasi-experimental study using post-test with control group design. Respondents were recruited by selecting pharmacists according to the inclusion criterion. The control group consisted of 26 pharmacists who made dose adjustments manually, and the intervention group consisted of 26 pharmacists who made dose adjustments using the Dosing GAMA application. Data were obtained by measuring the time required by the pharmacist to make dose adjustments. The intervention group was then asked to complete a perceived acceptance questionnaire. The study indicated that Dosing GAMA could reduce the time needed for dose adjustment evaluation (p<0.05). An average time spent by pharmacists with Dosing GAMA was shorter than that spent by those who made dose adjustments manually without application (13.81±0.78 min vs. 27.5±1.23 min). Overall, the pharmacists have high perceived acceptance of the application. The study results can be used as the basis for developing the application. Furthermore, it is expected that the Dosing GAMA can improve pharmacists’ performance in providing effective pharmaceutical care.